| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |